Arendt G. Neurologische Manifestationen der HIV-Infektion in der Ära der hochaktiven antiretroviralen Therapie (HAART). Fortschritte der Neurologie Psychiatrie 2005; 73: 577-586.

Arendt G, Nolting T. Neurologische Manifestationen der HIV-Infektion - ein Update. MMW Fortschritte der Medizin 2005; 147: 75-77.

Auer-Grumbach M, Schlotter-Weigel B, Lochmuller H, Strobl-Wildemann G, Auer-Grumbach P, Fischer R, Offenbacher H, Zwick EB, Robl T, Hartl G, Hartung HP, Wagner K, Windpassinger C and the Austrian peripheral neuropathy study group. Phenotypes of the N88S Beradinelli-Seip congenital lipodystrophy 2 mutation. Annals of Neurology 2005; 57: 415-424.

Azari NP, Missimer J, Seitz RJ. Religious Experience and Emotion: Evidence for distinctive cognitve neural patterns. International Journal of Psychology and Religion 2005; 15: 263-281.

Bernal F, Hartung HP, Kieseier BC. Tissue mRNA expression in rat of newly described matrix metalloproteinases. Biological Research 2005; 38: 267-271.

Biermann-Ruben K, Salmelin R, Schnitzler A. Right rolandic activitation during speech perception in stutterers: a MEG study. Neuroimage 2005; 25: 793-801.

Block F, Dihne M, Loos M. Inflammation in areas of remote changes following focal brain lesion.Progress in Neurobiology 2005; 75: 342-365.

Bütefisch CM, Kleiser R, Körber B, Müller K, Wittsack HJ, Hömberg V, Seitz RJ. Recruitment of contralesional motor cortex in stroke patients with recovery of hand function. Neurology 2005; 64: 1067-1069.

Cepok S, Zhou D, Srivastava R, Grummel V, Büssow K, Nessler S, Sommer N, Hemmer B. Identification of Epstein-Barr-Virus proteins as putative targets of the immune response in multiple sclerosis. Journal of Clinical Investigation 2005; 115: 1352-1360.

Cepok S, Rosche B, Grummel V, Vogel F, Zhou D, Sommer N, Hartung HP, Hemmer B. Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. Brain 2005; 128: 1667-1676.

Chen J, Bernreuther C, Dihné M, Schachner M. Cell adhesion molecule l1-transfected embryonic stem cells with enhanced survival support regrowth of corticospinal tract axons in mice after spinal cord injury. Journal of Neurotrauma 2005; 22: 896-906.

Evers S, Fiori W, Brockmeyer N, Arendt G, Husstedt IW. Recommendations for the classification of HIV associated neuromanifestations in the German DRG system. European Journal of Medical Research 2005; 10: 378-380.

Evers S, Fiori W, Brockmeyer N, Arendt G, Husstedt IW. Recommendations for the coding of neural manifestations of HIV-infections. Nervenarzt 2005; 76: 1544-1546.

Freynhagen R, Giesen HJv, Busche P, Sabatowski R, Konrad C, Grond S. Switching from reservoir to matrix systems for the transdermal delivery of fentanyl: a prospective, multicenter pilot study in outpatients with chronic pain. Journal of Pain und Symptom Management2005; 30: 289-297.

Frohman EM, Filippi M, Stüve O, Waxman SG, Corboy J, Phillips JT, Lucchinetti C, Wilken J, Karandikar N, Hemmer B, Monson N, DeKeyser J, Hartung HP, Steinman L, Oksenberg JR, Cree BAC, Hauser S, Racke MK. Characterizing the Mechanisms of Progression in Multiple Sclerosis: Evidence and New Hypotheses for Future Directions Archives of Neurology2005; 62: 1345-1356.

Frohman EM, Stüve O, Havrdova E, Corboy J, Achiron A, Zivadinov R, Sorensen PS, Phillips JT, Weinshenker B, Hawker K, Hartung HP, Steinman L, Zamvil S, Cree BA, Hauser S, Weiner H, Racke MK, Filippi M. Therapeutic Considerations for Disease Progression in Multiple Sclerosis: Evidence, Experience, and Future Expectations. Archives of Neurology2005; 62: 1519-1530.

Georgiadis D, Lanczik O, Schwab S, Engelter S, Sztajzel R, Arnold M, Siebler M, Schwarz S, Lyrer L, Baumgartner RW. Intravenous thrombolysis in patients with acute stroke due to spontaneous carotid dissection. Neurology 2005; 64: 1612-1614.

Giesen HJv, Haslinger BA, Rohe S, Koeller H, Arendt G. HIV Dementia Scale and Psychomotor Slowing - the best methods in screening for Neuro-AIDS. Journal of Neuropsychiatry Clinical Neurosciences 2005; 17: 185-191.

Giesen HJv, Adams O, Köller H, Haslinger B, Arendt G. Cerebrospinal fluid HIV-1 viral load in different phases of HIV-1 associated brain disease. Journal of Neurology 2005; 252: 801-807.

Gold R, Hartung HP. Towards individualised MS therapy. Lancet Neurology 2005; 4: 693-694.

Gold R, Kieseier BC, Hartung HP. Immunological properties of the peripheral nervous system. In: Antel J, Birnbaum G, Hartung HP (eds.) Clinical Neuroimmunology. 2nd ed. Oxford University Press, Oxford, 2005; 77-86.

Gold R, Stoll G, Kieseier BC, Hartung HP, Toyka KV. Experimental autoimmune neuritis (EAN). In: Dyck PJ, Thomas PK (eds.) Peripheral Neuropathies. 4th ed. WB Saunders, Philadelphia, 2005; 609-634.

Gross J, Pollok B, Dirks M, Timmermann L, Butz M, Schnitzler A. Task-dependent oscillations during unimanual and bimanual movements in the human primary motor cortex and SMA studied with magnetoencephalography. Neuroimage2005; 26: 91-98.

Haas J, Maas-Enriquez M, Hartung HP. Intravenous immunoglobulins in the treatment of relapsing remitting multiple sclerosis - results of a retrospective multicenter observational study over five years. Multiple Sclerosis 2005; 11: 562-567.

Hahn AF, Hartung HP, Dyck PJ. CIDP. In: Dyck PJ, Thomas PK (eds.) Peripheral Neuropathies. 4th ed. WB Saunders, London, 2005; 2221-2254.

Hartung HP. Early treatment and dose optimisation BENEFIT and BEYOND. Journal of Neurology 2005; 252, Suppl. 3: 44-50.

Hartung HP, Kieseier BC, Gold R, Stoll G, Toyka KV. Introduction to immune reactions in the PNS. In: Dyck PJ, Thomas PK (eds.) Peripheral Neuropathies. 4th ed. WB Saunders, Philadelphia, 2005; 559-572.

Hartung HP, Munschauer F, Schellekens H. Significance of neutralizing antibodies to interferon beta during treatment of multiple sclerosis: expert opinions based on the Proceedings of an International Consensus Conference. European Journal of Neurology2005; 12: 588-601.

Hartung HP, Kieseier BC, Hemmer B. Purely systemically active anti-inflammatory treatments are adequate to control multiple sclerosis. Journal of Neurology 2005; 252: 5: 30-37.

Heckel M, Kieseier BC, Schaper J, Mayatepek E, Rosenbaum T. Mitoxantrone as rescue therapy in two children with worsening multiple sclerosis. Journal of Pediatric Neurology2005; 237-242.

Hemmer B, Stüve O, Hartung HP. Basis of immunotherapy. In: Antel J, Birnbaum G, Hartung HP (eds.) Clinical Neuroimmunology. 2nd ed. Oxford University Press, Oxford, 2005; 21-32.

Hemmer B, Stüve O, Kieseier B, Hartung HP. Multiple sclerosis - Immune directed therapies. In: Antel J, Birnbaum G, Hartung HP (eds.) Clinical Neuroimmunology. 2nd ed. Oxford University Press, Oxford, 2005; 217-228.

Hemmer B, Stüve O, Kieseier, B, Schellekens H, Hartung HP. Immune response to immunotherapy: the role of neutralising antibodies to interferon beta in the treatment of multiple sclerosis. Lancet Neurology 2005; 4: 403-412.

Hirsch MA, Westhoff B, Toole T, Haupenthal S, Krauspe R, Hefter H. Association between botulinum toxin injecton into the arm and changes in gait in adults after stroke. Movement Disorders, 2005; 20: 1014-1020.

Hömberg V. Evidence based medicine in neurological rehabilitation. A critical review. Acta Neurochirurgica 2005; Suppl. 93: 3-14.

Jander S, Hartung HP. Aktuelle Aspekte in der Pathogenese, Diagnostik und Therapie der Myasthenia gravis. Aktuelle Neurologie 2005; 32: 3-9.

Jander S. Neuroinflammation und Schlaganfall. Nervenheilkunde 2005; 24: 82-88.

Kahles T, Foerch C, Sitzer M, Schroeter M, Steinmetz H, Rami A, Neumann-Haefelin T. Tissue plasminogen activator mediated blood-brain barrier damage in transient focal cerebral ischemia in rats: Relevance of interactions between thrombotic material and thrombolytic agent. Vascular Pharmacology 2005; 43: 254-259.

Kappos L, Hartung HP. 10 years of interferon beta-1b (Betaferon®) therapy. Journal of Neurology 2005; 252, Suppl. 3: 1-2.

Kappos L, Clanet M, Sandberg-Wollheim M, Radue EW, Hartung HP, Hohlfeld R, Xu J, Bennett D, Sandrock A, Goelz S, European Interferon Beta-1a IM Dose-Comparison Study Investigators. Neutralizing antibodies and efficacy of interferon beta-1a: a 4-year controlled study. Neurology 2005; 65: 40-47.

Kastenbauer S, Kieseier BC, Becker BF. No evidence of increased oxidative degradation of urate to allantoin in the CSF and serum of patients with multiple sclerosis. Journal of Neurology 2005; 252: 611-612.

Kawakami N, Odoardi F, Ziemssen T, Bradl M, Ritter T, Neuhaus O, Lassmann H, Wekerle H, Flügel A: Autoimmune CD4+ T cell memory: life long persistence of encephalitogenic T cell clones in healthy immune repertoires. Journal of Immunology 2005; 175: 69-81.

Kessler K, Schmitz F, Gross J, Hommel B, Shapiro K, Schnitzler A. Cortical mechanisms of attention in time: Neural correlates of the lag-1-sparing phenomenon. European Journal of Neuroscience 2005; 21: 2563-2574.

Kessler K, Schmitz F, Gross J, Hommel B, Shapiro K, Schnitzler A. Target consolidation under high temporal processing demands as revealed by MEG. Neuroimage 2005; 26: 1030-1041.

Kieseier BC, Hemmer B, Hartung HP. Multiple sclerosis - novel insights and new strategies. Current Opinion in Neurology 2005; 18: 211-220.

Kieseier BC, Bernal F. Proteases in CNS infection and inflammation. In: Lendeckel U, Hooper NM (eds.) Proteases in the Brain. Springer, New York, 2005; 109-137.

Kieseier BC, Hartung HP. Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. In: Antel J, Birnbaum G, Hartung HP (eds.) Clinical Neuroimmunology. 2nd ed. Oxford University Press, Oxford, 2005; 229-238.

Klapka N, Hermanns S, Straten G, Masanneck C. Duis S., Hamers F, Müller D, Zuschratter W, Müller HW. Suppression of fibrous scarring in spinal cord injury of rat promotes long-distance regeneration of corticospinal tract axons, rescue of primary motoneurons in somatosensory cortex and significant functional recovery. European Journal of Neuroscience2005; 22, 3047-3058.

Kleiser R, Wittsack HJ, Bütefisch CM, Jörgens S, Seitz RJ. Functionsal activation within the PI-DWI mismatch region in recovery from hemiparetic stroke: preliminary observations. Neuroimage 2005; 24: 515-523.

Klusmann A, Fleischer W, Waldhaus A, Sieberl M, Mayatepek E. Influence of D-arabitol and ribitol on neuronal network activity. Journal of Inherited Metabolic Disease 2005; 28: 1181-1183.

Kobsar I, Hasenpusch-Theil K, Wessig C, Müller HW, Martini R. Evidence for macrophage-mediated myelin disruption in an animal model for Charcot-Marie-Tooth neuropathy type 1A. Journal of Neuroscience Research 2005; 81: 857-864.

Köller H, Neuhaus O, Schroeter M, Hartung HP. Myopathien unter der Therapie mit Lipidsenkern. Nervenarzt 2005; 76: 212-217.

Köller H, Hartung HP. Neuromuscular Rehabilitation: Diseases of the motor neuron, peripheral nerve, and neuromuscular junction. In: Selzer M, Clarke S, Cohen L, Duncan P, Gage F (eds.) Textbook of neural repair and rehabilitation. Vol. II. Cambridge University Press, Cambridge, 2005; 657-676.

Köller H, Schroeter M, Kieseier BC, Hartung HP. Chronic inflammatory demyelinating polyneuropathy - update on pathogenesis, diagnostic criteria and therapy. Current Opinion in Neurology 2005; 18: 273-278.

Köller H, Kieseier BC, Jander S, Hartung HP. Chronic inflammatory demyelinating polyneuropathy. New England Journal of Medicine 2005; 352: 1343-1356.

Köller H, Neuhaus O, Schroeter M, Hartung HP: Myopathien unter der Therapie mit Lipidsenkern. Nervenarzt 2005; 76: 212-217.

Konen CS, Kleiser R, Seitz RJ, Bremmer F. An fMRI study of optokinetic nystagmus and smooth-pursuit eye movements in humans. Experimental Brain Research 2005; 165: 203-216.

Krapf H, Morrissey SP, Zenker O, Zwingers T, Gonsette R, Hartung HP, MIMS Study Group. Effect of mitoxantrone on MRI in progressive MS: results of the MIMS trial. Neurology 2005; 65: 690-695.

Küry P, Zickler P, Stoll G, Hartung HP, Jander S. Osteopontin, a macrophage-derived matricellular glycoprotein inhibits axon outgrowth. FASEB Journal 2005; 19: 398-400.

Kurz M, Pischel H, Hartung HP, Kieseier, BC. Tumor necrosis factor-alpha converting enzyme is expressed in the inflamed peripheral nervous system. Journal of the Peripheral Nervous System 2005; 10: 311-318.

Lietz M, Ulrrich A, Schulte-Eversum C, Oberhoffner S, Fricke C, Müller HW, Schlosshauer B. Physical and biological performance of a novel block copolymer nerve guide. Biotechnology and Bioengineering 2005; 93: 99-109.

Lovett-Racke AE, Cravens PD, Gocke AR, Racke MK, Stuve O. Therapeutic potential of small interfering RNA for central nervous system diseases. Archives of Neurology 2005; 62: 1810-1812.

Markus HS, Droste DW, Kaps M, Larrue V, Lees KR, Siebler M, Ringelstein EB. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation 2005; 111: 2233-2240.

Menge T, Hartung HP, Stuve O. Statins - A cure-all for the brain? Nature Reviews Neurosciences 2005; 6: 325-331.

Menge T, von Büdingen HC, Zamvil SS, Hartung HP, Kieseier BC, Stüve O. Statine zur Behandlung von Erkrankungen des zentralen Nervensystems? Eine Standortbestimmung aus Forschung und Klinik. Nervenarzt 2005; 76: 426-437.

Menge T, Hemmer B, Nessler S, Wiendl H, Neuhaus O, Hartung HP, Kieseier BC, Stüve O. Acute disseminated encephalomyelitis: an update. Archives of Neurology 2005; 62: 1673-1680.

Menge T, Lalive PH, von Büdingen HC, Cree B, Hauser SL, Genain CP. Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis. Journal of Allergy and Clinical Immunology 2005; 116: 453-459.

Mitsdörffer M, Schreiner B, Kieseier BC, Neuhaus O, Dichgans J, Hartung HP, Weller M, Wiendl H. Monocyte-derived HLA-G acts a strong inhibitor of autologous CD4 T-cell activation and is upregulated by interferon-b in vitro and in vivo: rationale for the therapy of multiple sclerosis. Journal of Neuroimmunology 2005; 159: 155-164.

Muller BT, Huber R, Henrich B, Adams O, Berns G, Siebler M, Jander S, Muller W, Loncar R, Godehardt E, Sandmann W. Chlamydia pneumoniae, herpes simplex virus and cytomegalovirus in symptomatic and asymptomatic high-grade internal carotid artery stenosis. Does infection influence plaque stability? Vasa 2005; 34: 163-169.

Neuhaus O, Wiendl H, Kieseier BC, Archelos JJ, Hemmer B, Stüve O, Hartung HP. Multiple sclerosis: mitoxantrone promotes differential effects on immunocompetent cells in vitro. Journal of Neuroimmunology 2005; 168: 128-137.

Neuhaus O, Stüve O, Archelos JJ, Hartung HP. Putative mechanisms of action of statins in multiple sclerosis - comparison to interferon-b and glatiramer acetate. Journal of the Neurological Sciences 2005; 233: 173-177.

Neuhaus O, Stüve O, Zamvil SS, Hartung HP. Evaluation of hydroxy-methylglutaryl coenzyme A reductase inhibitors for multiple sclerosis - opportunities and obstacles. CNS Drugs 2005; 19: 833-841.

Neuhaus O, Kieseier BC, Hartung HP. Mechanisms of action of current therapeutics and promising future candidates in multiple sclerosis. In: Columbus F (ed.) Treatment and Management of Multiple Sclerosis. Nova Biomedical Books, New York, 2005; 1-32.

Nickel J, Seitz RJ. Functional clusters in the human parietal cortex as revealed by an observer-independent meta-analysis of functional activation studies. Anatomy and Embryology 2005; 210: 463-472.

Otto F, Kieseier BC, Görtz P, Hartung HP, Siebler M. The pentapeptide QYNAD does not inhibit neuronal network. Canadian Journal of the Neurological Sciences 2005; 32: 344-348.

Ploner M, Turowski B, Wobker G. Herpes encephalitis after rmeningioma resection. Neurology 2005; 65: 1674-1675.

Pollard JD, Hughes R, Hartung HP. Fundamentals of immune therapy. In: Dyck PJ, Thomas PK (eds.) Peripheral Neuropathy. 4th ed., WB Saunders, London, 2005; 635-648.

Pollok B, Gross J, Müller K, Aschersleben G, Schnitzler A. Oscillatory Network Associated with Auditorily Paced Finger Movements. Neuroimage 2005; 24: 646-655.

Pollok B, Schnitzler I, Stoerig P, Mierdorf T, Schnitzler A. Image-to-sound conversion: experience-induced plasticity in auditory cortex of blindfolded adults. Experimental Brain Research 2005; 167: 287-291.

Pollok B, Suedmeyer M, Gross J, Schnitzler A. The oscillatory network of simple repetitive bimanual movements. Brain Research Cognitive Brain Research 2005; 25: 300-311.

Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS. Diagnostic Criteria for Multiple Sclerosis: 2005 Revisions to the "McDonald" Criteria. Annals of Neurology 2005; 58: 840-846.

Rice GP, Hartung HP, Calabresi PA. Anti-alpha4 integrin therapy for multiple sclerosis: mechanisms and rationale. Neurology 2005; 64: 1336-1342.

Rieckmann P, Kruse N, Nagelkerken L, Beckmann K, Miller D, Polman C, Dahlke F, Toyka KV, Hartung HP, Sturzebecher S. Soluble vascular cell adhesion molecule (VCAM) is associated with treatment effects of interferon beta-1b in patients with Secondary Progressive Multiple Sclerosis. Journal of Neurology 2005; 252: 526-533.

Schlitter AM, Kurz M, Larsen JP, Woitalla D, Muller T, Epplen JT, Dekomien G. Exclusion of PINK1 as candidate gene for the late-onset form of Parkinson's disease in two European populations. Journal of Negative Results in Biomedicine 2005; 4: 10.

Schnitzler A, Gross J. Magnetenzephalographie: In: Walter H (ed.) Funktionelle Bildgebung des Gehirns in Psychiatrie und Psychotherapie: Methodische Grundlagen und klinische Anwendungen. Schattauer Verlag, Stuttgart, 2005; 151-161.

Schnitzler A, Gross J. Functional connectivity analysis in magnetoencephalography. International Reviews in Neurobiology2005; 68: 173-195.

Schnitzler A, Gross J. Normal and pathological oscillatory communication in the brain. Nature Reviews Neurosciences 2005; 6: 285-296.

Schreiner B, Kieseier BC, Hartung HP, Hohlfeld R, Wiendl H. Blockade von Adhäsionsmolekülen mit Natalizumab (TYSABRI®, vormals ANTEGREN®) in der Therapie der Multiplen Sklerose - Aktueller Studienstand. Nervenarzt 2005; 76: 999-1005.

Schroeter M, Hartung HP. Epidemiologie, Diagnostik und Differenzialdiagnose der diabetischen Polyneuropathie. Psychoneuro 2005, 31: 569-574.

Schroeter M, Jander S. T-cell cytokines in injury-induced neural damage and repair. Neuromolecular Medicine 2005; 7: 183-196.

Schwarz J, Baas H, Ebersbach G, Jörg J, Kuhn W, Rieke G, Schnitzler A. Formen und Ausprägungen von Spätkomplikationen bei M. Parkinson Aktuelle Neurologie 2005; 32, Suppl. 3: 5102-5105.

Seitz RJ, Meisel S, Moll M, Wittsack HJ, Junghans U, Siebler M. Partial rescue of the perfusion deficit area by thrombolysis. Journal of Magnetic Resonance Imaging 2005; 22: 199-205.

Seitz RJ, Meisel S, Weller P, Junghans U, Wittsack HJ, Siebler M. Initial ischemic event: perfusion-weighted MR imaging and apparent diffusion coefficient for stroke evolution. Radiology 2005; 237: 1020-1028.

Seitz RJ, Kleiser R, Bütefisch CM. Reorganization of cerebral circuits in human brain lesion. Acta Neurochirurgica 2005; Suppl. 93: 65-70.

Sinis N, Schaller HE, Schulte-Eversum C, Schlosshauer B, Doser M, Dietz K, Rösner H, Müller HW, Herle M. Nerve regeneration across a 2 cm gap in the rat median nerve using an resorbable nerve conduit filled with Schwann cells. Journal of Neurosurgery 2005; 103: 1067-1076.

Steinbeck JA, Methner, A. Translational downregulation of the non-catalytic growth factor receptor TrkB.T1 by ischemic preconditioning of primary neurons. Gene Expression 2005; 12: 99-106.

Stoeckel MC, Pollok B, Witte OW, Seitz RJ, Schnitzler A. Shrinkage of somatosensory hand area in subjects with upper extremity dysmelia revealed by magnetoencephalography. Journal of Neurophysiology 2005; 93: 813-818.

Stoeckel MC, Jörgens S, Witte OW, Seitz RJ. Reduced somatosensory hand representation in thalidomide-induced dysmelia as revealed by fMRI. European Journal of Neuroscience2005; 21: 556-562.

Stoll G, Jander S, Nadareishvili Z, Hallenbeck J. Immunological Aspects of Ischemic Stroke. In: Antel, Birnbaum, Hartung, Vincent (eds.) Clinical Neuroimmunology. Oxford University Press, Oxford, 2005; 403-412.

Stüve O, Cepok S, Elias B, Saleh A, Hartung HP, Hemmer B, Kieseier B. Clinical stabilization and effective B-cell depletion in the cerebrospinal fluid and peripheral blood in a patient with fulminant relapsing remitting multiple sclerosis. Archives of Neurology 2005; 62: 1620-1623.

Stüve O, Nessler S, Hartung HP, Hemmer B, Wiendl H, Kieseier BC. Pathogenese, Diagnose, Behandlung, und Prognose der akuten disseminierten Enzephalomyelitis. Nervenarzt 2005; 76: 701-707.

Suchan B, Melde C, Hömberg V, Seitz RJ. Cingulate cortex activation and competing responses: the role of preparedness for competition. Behavioural Brain Research 2005; 163: 219-226.

Thomsen S, Leweren, J, Steinbeck JA, Methner A. Short-term serum supplementation improves glucose-oxygen deprivation in primary cortical cultures grown under serum-free conditions. Methods in Cell Science 2005; 25: 227-236.

Timmermann L, Gross J, Butz M, Kircheis G, Haussinger D, Schnitzler A. Neural synchronization in hepatic encephalopathy. Metabolic Brain Disorders 2005; 20: 337-346.

Trostdorf F, Buchkremer M, Harmjanz A, Kablau M, Jander S, Geiger K, Schmidt-Rixen T, Steinmetz H, Sitzer M. Fibrous cap thickness and smooth muscle cell apoptosis in high-grade carotid artery stenosis. European Journal of Vascular and Endovascular Surgery 2005; 29: 528-535.

Westphalen B, Wessig J, Leypoldt F, Arnold S, Methner A. BI-1 protects cells from oxygen glucose deprivation by reducing the calcium content of the endoplasmic reticulum. Cell Death and Differentiation 2005; 12: 304-306.

Wiendl H, Feger U, Mittelbronn M, Schreiner B, Stadelmann C, Antel J, Brueck W, Meyermann R, Bar-Or A, Kieseier BC, Weller M. Expression of the non-classical major histocompatibility molecule HLA-G in multiple sclerosis: implication for CNS immunity. Brain2005; 128: 2689-2704.

Wiendl H, Hohlfeld R, Kieseier BC. The immunobiology of muscle: advances in understanding an immunological microenvironment. Trends in Immunology 2005; 26: 373-380.

Wiendl H, Hohlfeld R, Kieseier BC. Muscle derived positive and negative regulators of the immune response. Current Opinion in Rheumatology 2005; 17: 714-719.

Zickler P, Seitz RJ, Hartung HP, Hefter H. Bilateral medullary pyramid infarction. Neurology2005; 64: 1801.


Ziemssen T, Kümpfel T, Schneider H, Klinkert WEF, Neuhaus O, Hohlfeld R. Secretion of brain-derived neurotrophic factor by glatiramer acetate-reactive T-helper cell lines: implications for multiple sclerosis therapy. Journal of the Neurological Sciences 2005; 233: 109-112.

MediathekInformation und Wissen
LageplanSo finden Sie uns